Synergy of Arbekacin-based Combinations Against Vancomycin Hetero-intermediate Staphylococcus aureus
Journal of Korean Medical Science
;
: 188-192, 2006.
Artículo
en Inglés
| WPRIM
| ID: wpr-79366
ABSTRACT
This study was undertaken to evaluate the in vitro activities of arbekacin-based combination regimens against vancomycin hetero-intermediate Staphylococcus aureus (hetero-VISA). Combinations of arbekacin with vancomycin, rifampin, ampicillin-sulbactam, teicoplanin, or quinipristin-dalfopristin against seven hetero-VISA strains and two methicillin-resistant S. aureus strains were evaluated by the time-kill assay. The combinations of arbekacin with vancomycin, teicoplanin, or ampicillinsulbactam showed the synergistic interaction against hetero-VISA strains. Data suggest that these arbekacin-based combination regimens may be useful candidates for treatment options of hetero-VISA infections.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Infecciones Estafilocócicas
/
Staphylococcus aureus
/
Dibekacina
/
Vancomicina
/
Pruebas de Sensibilidad Microbiana
/
Sulbactam
/
Resistencia a la Meticilina
/
Virginiamicina
/
Teicoplanina
/
Farmacorresistencia Bacteriana
Límite:
Humanos
Idioma:
Inglés
Revista:
Journal of Korean Medical Science
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS